News & Insights

Markets
ARAY

Accuray Gets FDA Clearance For ClearRT Helical KVCT Imaging For Radixact Treatment Delivery System

January 05, 2021 — 07:39 am EST

Written by RTTNews.com for RTTNews->

(RTTNews) - Accuray Inc. (ARAY) said that it has received 510(k) clearance from the U.S. Food and Drug Administration for its ClearRT Helical kVCT Imaging for the Radixact System, the next generation TomoTherapy platform.

ClearRT is a cutting-edge imaging solution integrated with a precise, and adaptive delivery platform, designed to produce exceptional diagnostic-like quality CT images, quickly and cost-effectively, to improve patient care.

Accuray said it plans commercial release of the ClearRT Helical kVCT Imaging for the Radixact System in the Spring of 2021.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

ARAY

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.